About the Company
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $AMAG News
Activist Fund Manager Ups Stake in Amag Pharma to Stop Merger With Allos
Hedge fund manager Martin Shkreli now own 5% of Amag and is seeking to replace directors to stop a planned merger with Allos Therapeutics. Hedge fund manager Martin Shkreli now own 5% of Amag and ...
AMAG Pharmaceuticals Completes Divestment of Women’s Health Assets
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced AMAG and Palatin Technologies, Inc. have mutually terminated the January 2017 license agreement pursuant to which AMAG was granted ...
Why This New FDA-approved Drug Vyleesi Is Not 'Female Viagra'
Another difference between Vylessi, which will be marketed by AMAG Pharmaceuticals, and Viagra is their routes of administration. Viagra goes into your mouth, or at least you it should ...
Covis Group Announces Agreement to Acquire AMAG Pharmaceuticals
Covis Group S.à r.l. (“Covis”) and AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that they have entered into a definitive agreement under which Covis will acquire AMAG for $13.75 ...
FDA pulls preterm-birth drug Makena and its generics from market after 12 years
The U.S. Food and Drug Administration said Thursday it had reached a final decision to fully withdraw approval of preterm-birth drug Makena and its generics, a full 12 years after the treatment ...
Contact AMAG Technology, Inc.
AMAG Technology is a provider of fully integrated security solutions throughout the world, protecting everything from small offices and schools to large multi-national organizations and high security ...
Madrigal Prices Upsized Public Offering Of $600 Mln Of Shares
(RTTNews) - Madrigal Pharmaceuticals, Inc. (MDGL), a company focused on nonalcoholic steatohepatitis, said that it has priced its upsized public offering of 750,000 shares at $260 per share and ...
Guardant Health Inc (GH)
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) incurred a loss of $1.28 per share in the second quarter of 2019, much wider than the Zacks Consensus Estimate of a loss of 66 cents as ...
Amylyx Pharmaceuticals Inc AMLX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Ionis Pharmaceuticals Inc IONS
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The Sodium-Potassium Seesaw: Help Patients Balance
Both the medical and lay literature have entertained much discussion about the role of diet in general and sodium intake specifically to minimize population risk for cardiovascular disease and ...
PCSA Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing the chemotherapy drugs to improve the safety and efficacy of cancer treatment. Its drugs are ...
Loading the latest forecasts...